5 Biggest Biotechnology ETFs in 2026
Source: Investing News Network
2026-06-02 16:10:00 ET
The biotech sector has made significant strides in recent years, and the market's volatility can increase the appeal of biotech ETFs.
Even with a good understanding of the system, no one can predict which treatment, device or therapy will give the biggest return, making biotech exchange-traded funds (ETFs) a more secure option than individual biotech stocks.
An ETF is a relatively safe investment route that can minimize losses while offering exposure to multiple companies instead of focusing on the gains and losses of a single biotech stock.
For further details see:
5 Biggest Biotechnology ETFs in 2026
Vertex Pharmaceuticals Incorporated
NASDAQ: VRTX
VRTX Trading
2.32% G/L:
$452.60 Last:
534,454 Volume:
$445.605 Open:
VRTX Latest News
June 05, 2026 12:00:00 pm
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference
June 03, 2026 04:00:00 pm
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
VRTX Stock Data
$118,425,801,558
253,211,393
0.21%
875
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
